SanBio Company Limited
General ticker "SNBIF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $666.4M (TTM average)
SanBio Company Limited follows the US Stock Market performance with the rate: 42.3%.
Estimated limits based on current volatility of 0.0%: low 16.45$, high 16.45$
Factors to consider:
- Earnings expected soon, date: 2025-12-15 bmo
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [2.79$, 7.07$]
- 2026-01-31 to 2027-01-31 estimated range: [1.95$, 5.18$]
Financial Metrics affecting the SNBIF estimates:
- Positive: with PPE of -16.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.24 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 51.14 <= 63.39
- Positive: Interest expense per share per price, % of 0.01 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.01 > -0.66
- Negative: negative Net income
Short-term SNBIF quotes
Long-term SNBIF plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | ¥0.00MM | ¥0.00MM | ¥0.00MM |
| Operating Expenses | ¥7,899.31MM | ¥4,539.73MM | ¥3,516.00MM |
| Operating Income | ¥-7,899.31MM | ¥-4,539.73MM | ¥-3,516.00MM |
| Non-Operating Income | ¥3,201.86MM | ¥1,997.59MM | ¥507.00MM |
| Interest Expense | ¥25.27MM | ¥25.81MM | ¥6.00MM |
| R&D Expense | ¥6,118.12MM | ¥2,849.59MM | ¥2,357.00MM |
| Income(Loss) | ¥-4,697.44MM | ¥-2,542.14MM | ¥-3,009.00MM |
| Taxes | ¥0.00MM | ¥102.20MM | ¥-127.00MM |
| Profit(Loss)* | ¥-5,559.58MM | ¥-2,644.33MM | ¥-2,753.33MM |
| Stockholders Equity | ¥4,428.91MM | ¥2,792.40MM | ¥1,762.92MM |
| Assets | ¥7,045.11MM | ¥5,047.29MM | ¥3,447.34MM |
| Operating Cash Flow | ¥-7,434.15MM | ¥-4,765.65MM | ¥-3,603.11MM |
| Capital expenditure | ¥8.00MM | ¥54.97MM | ¥4.89MM |
| Investing Cash Flow | ¥-10.10MM | ¥-19.03MM | ¥-4.27MM |
| Financing Cash Flow | ¥9,445.78MM | ¥2,370.53MM | ¥2,091.01MM |
| Earnings Per Share** | ¥-95.99 | ¥-40.48 | ¥-39.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.